SHIRE HUMAN GENETIC THERAPIES, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 57110
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 49206
 
 
 
C07K PEPTIDES 23113
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 14111
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 13193
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 891
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 495
 
 
 
G06F ELECTRIC DIGITAL DATA PROCESSING 3444
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 293
 
 
 
A47B TABLES; DESKS; OFFICE FURNITURE; CABINETS; DRAWERS; GENERAL DETAILS OF FURNITURE 151

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0071,212 METHODS AND COMPOSITIONS FOR CNS DELIVERY OF ARYLSULFATASE AAug 23, 17Mar 15, 18[A61K]
2018/0051,315 ENZYMATIC ACTIVITY ASSAYS FOR GLUCOCEREBROSIDASEDec 16, 15Feb 22, 18[C12Q]
2018/0036,386 METHODS AND COMPOSITIONS FOR INTRATHECALLY ADMINISTERED TREATMENT OF MUCUPOLYSACCHARIDOSIS TYPE IIIAJul 12, 17Feb 08, 18[A61K]
2018/0009,904 LYSOSOMAL TARGETING AND USES THEREOFNov 20, 15Jan 11, 18[A61K, C12N, C07K]
2018/0010,108 CELLS FOR PRODUCING RECOMBINANT IDURONATE-2-SULFATASEJul 14, 17Jan 11, 18[C12N]
2017/0360,905 Conjugated C1 Esterase Inhibitor and Uses ThereofApr 04, 17Dec 21, 17[A61K, C07K]
2017/0362,632 ENZYMATIC ACTIVITY ASSAYS FOR I2SDec 17, 15Dec 21, 17[C12Q]
2017/0267,986 GENERATION OF MANNOSE-6-PHOSPHATE CONTAINING RECOMBINANT ALPHA-N-ACETYL GLUCOSAMINIDASEJun 25, 15Sep 21, 17[A61K, C12N]
2017/0232,076 MANNOSE-6-PHOSPHATE BEARING PEPTIDES FUSED TO LYSOSOMAL ENZYMESAug 11, 15Aug 17, 17[A61K, C12N, C07K]
2017/0131,293 BIOMARKERS FOR SANFILIPPO SYNDROME AND USES THEREOFJun 16, 16May 11, 17[G01N]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9814764 Treatment of sanfilippo syndrome type b by intrathecal administration of alpha-n-acetylglucosaminidaseMay 10, 13Nov 14, 17[A61K, C12N, C07K]
9770410 Methods and compositions for CNS delivery of arylsulfatase AJun 25, 11Sep 26, 17[A61K]
9719074 Cells for producing recombinant iduronate-2-sulfataseAug 21, 15Aug 01, 17[C12N]
9708590 Crystal structure of human α-N-acetylglucosaminidaseJul 07, 14Jul 18, 17[C12Q, C12N, G01N]
9694057 Stabilized compositions of proteins having a free thiol moietyJun 18, 15Jul 04, 17[A61K, C12N, B65B]
9682129 Treatment of cognitive impairment of hunter syndrome by intrathecal delivery of iduronate-2-sulfataseDec 21, 12Jun 20, 17[A61K, C12N]
9623090 Compositions and methods for treating type III gaucher diseaseMar 01, 13Apr 18, 17[A61K, G01N]
9603908 Subcutaneous administration of iduronate-2-sulfataseMar 14, 13Mar 28, 17[A61K]
9597376 Lipoprotein lipase for treatment of hypertriglyceridemic-related conditions including acute pancreatitisAug 19, 15Mar 21, 17[A61K]
9567585 Antisense oligonucleotide modulators of serotonin receptor 2C and uses thereofNov 09, 12Feb 14, 17[C12N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0202,929 LIPOPROTEIN LIPASE FOR TREATMENT OF HYPERTRIGLYCERIDEMIC-RELATED CONDITIONS INCLUDING ACUTE PANCREATITISAbandonedJan 20, 17Jul 20, 17[A61K, C12N]
2017/0004,827 Data Collection and Reporting System and MethodAbandonedJun 30, 15Jan 05, 17[G10L, G06F]
2016/0289,319 ANTI-CCL2 ANTIBODIES FOR TREATMENT OF SCLERODERMAAbandonedJan 29, 16Oct 06, 16[C07K]
2016/0030,416 METHODS OF TREATING B2-BRADYKININ RECEPTOR MEDIATED ANGIOEDEMAAbandonedMar 12, 14Feb 04, 16[A61K]
2015/0313,971 METHODS AND COMPOSITIONS FOR INTRATHECALLY ADMINISTERED TREATMENT OF MUCUPOLYSACCHARIDOSIS TYPE IIIAAbandonedDec 06, 13Nov 05, 15[A61K]
2015/0260,657 ASSAYS FOR DETECTION OF GLYCOSAMINOGLYCANSAbandonedMar 23, 15Sep 17, 15[G01N]
2015/0158,942 ANTI-CCL2 ANTIBODIES FOR TREATMENT OF SCLERODERMAAbandonedMay 22, 13Jun 11, 15[C07K]
2015/0017,672 ASSAYS FOR DETECTION OF GLYCOSAMINOGLYCANSAbandonedFeb 01, 13Jan 15, 15[C12Q]
2014/0350,089 OPTIMIZED MESSENGER RNAAbandonedMar 03, 14Nov 27, 14[C12N]
2014/0057,296 ASSAYS FOR ANTIBODIES WHICH BIND TO THERAPEUTIC AGENTSAbandonedMar 01, 12Feb 27, 14[G01N]
2014/0037,612 SUBCUTANEOUS ADMINISTRATION OF ALPHA-GALACTOSIDASE AAbandonedMay 24, 13Feb 06, 14[A61K]
2014/0004,097 METHOD OF PRODUCING RECOMBINANT IDURONATE-2-SULFATASEAbandonedMar 14, 13Jan 02, 14[C12N]
2013/0337,482 ASSAYS AND KITS TO DETERMINE GALACTOCEREBROSIDASE ACTIVITY ON SOLID SUPPORTAbandonedOct 28, 11Dec 19, 13[C12Q]
2013/0295,071 METHODS AND COMPOSITIONS FOR CNS DELIVERY OF B-GALACTOCEREBROSIDASEAbandonedApr 12, 13Nov 07, 13[A61K]
2013/0172,403 GENE THERAPY FOR SULFATASE DEFICIENCYAbandonedFeb 27, 12Jul 04, 13[A61K]
2013/0121,984 BIOMARKERS FOR SANFILIPPO SYNDROME AND USES THEREOFAbandonedNov 07, 12May 16, 13[A61K, C12Q]
2013/0028,881 DIAGNOSIS AND TREATMENT OF MULTIPLE SULFATASE DEFICIENCY AND OTHER SULFATASE DEFICIENCIESAbandonedJun 20, 12Jan 31, 13[A61K, C12P, C12N, A61P]
2012/0329,133 PROCESS FOR PURIFYING HEPARAN-N-SULFATASEAbandonedMay 18, 12Dec 27, 12[C12N]
2011/0318,324 METHODS AND COMPOSITIONS FOR CNS DELIVERY OF B-GALACTOCEREBROSIDASEAbandonedJun 25, 11Dec 29, 11[A61K, A61P]
2011/0318,327 TREATMENT OF SANFILIPPO SYNDROME TYPE BAbandonedJun 25, 11Dec 29, 11[A61K, C12N, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.